A Randomized Study on Postrelapse Disease-Free Survival with Adjuvant Mistletoe versus Oral Etoposide in Osteosarcoma Patients.

Evid Based Complement Alternat Med · 2014 · PMC3988743 · PMID 24803944

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

Regardless of these unresolved issues, so far the results indicate a positive trend in PRDFS for Viscum compared to historical control, and descriptively also compared to Etoposide.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.